An update on neuropsychiatric lupus with emphasis in cognitive dysfunction

dc.creatorLeon, Tomas
dc.creatorHenriquez, Carla
dc.creatorCalderon, Jorge
dc.creatorMassardo, Loreto
dc.date.accessioned2024-01-10T12:04:16Z
dc.date.accessioned2024-05-02T17:58:09Z
dc.date.available2024-01-10T12:04:16Z
dc.date.available2024-05-02T17:58:09Z
dc.date.created2024-01-10T12:04:16Z
dc.date.issued2012
dc.identifier10.4067/S0034-98872012001000015
dc.identifier0717-6163
dc.identifier0034-9887
dc.identifierMEDLINE:23559293
dc.identifierhttps://doi.org/10.4067/S0034-98872012001000015
dc.identifierhttps://repositorio.uc.cl/handle/11534/75743
dc.identifierWOS:000311884500015
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9269478
dc.description.abstractPatients with systemic lupus erythematosus (SLE) suffer from a number of neuropsychiatric (NP) symptoms throughout their disease affecting them both physically and psychologically We review herein the nomenclature and case definitions for neuropsychiatric lupus syndromes proposed by the American College of Rheumatology in 1999. We emphasize cognitive dysfunction and discuss etiological hypotheses, especially those related to the presence of antineuronal autoantibodies. (Rev Med Chile 2012; 140; 1333-1341).
dc.languagees
dc.publisherSOC MEDICA SANTIAGO
dc.rightsregistro bibliográfico
dc.subjectAutoantibodies
dc.subjectLupus erythematosus systemic
dc.subjectNeurobehavioral manifestations
dc.subjectGLUTAMATE-RECEPTOR ANTIBODIES
dc.subjectNERVOUS-SYSTEM INVOLVEMENT
dc.subjectP-PROTEIN ANTIBODIES
dc.subjectBLOOD-BRAIN-BARRIER
dc.subjectCEREBROSPINAL-FLUID
dc.subjectCLINICAL-SIGNIFICANCE
dc.subjectPSYCHIATRIC-SYMPTOMS
dc.subjectSLE PATIENTS
dc.subjectERYTHEMATOSUS
dc.subjectIMPAIRMENT
dc.titleAn update on neuropsychiatric lupus with emphasis in cognitive dysfunction
dc.typeartículo


Este ítem pertenece a la siguiente institución